Liver Bioregulator Research: Hepatocyte Peptide Studies
Liver bioregulator research: BPC-157, AICAR, and SS-31 studied in hepatocyte cell and animal models. Liver cell and metabolic pathway data.
Liver bioregulator research: BPC-157, AICAR, and SS-31 studied in hepatocyte cell and animal models. Liver cell and metabolic pathway data.
A research overview of AOD-9604, HGH Fragment 176-191, and 5-Amino-1MQ: three compounds studied in adipocyte cell models for distinct metabolic mechanisms.
A research overview of dulaglutide: a GLP-1R agonist with an IgG4 Fc fusion, studied in cell and animal models for GLP-1R binding and cAMP signaling.
A research overview of CagriSema: a cagrilintide and semaglutide combination studied as a dual amylin and GLP-1 receptor agonist in animal models.
A research overview of cagrilintide: a long-acting amylin analog, with findings from cell and animal model studies on receptor activation and mechanism.
GLP-1 research peptides bind the GLP-1 receptor. This guide covers GLP-1R mechanism, semaglutide, tirzepatide, and retatrutide for lab teams.
Research on tirzepatide as a dual GIP-R and GLP-1R agonist. Published cell model data on receptor binding, cAMP signal, and incretin receptor studies.
A research overview of 5-amino-1MQ: how it inhibits NNMT enzyme activity, its role in SAM and NAD+ pathways, and lab study findings in rodent models.
SLU-PP-322 research covers how this ERR nuclear receptor agonist activates metabolic gene programs, key rodent data, and structural properties.
Retatrutide research: triple GLP-1, GIP, and glucagon receptor agonist mechanisms, Phase 2 study design data, and COA-verified lab-grade sourcing.